Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2000-4-26
pubmed:abstractText
HLA class II DR is one of the most abundant cell surface proteins incorporated onto human immunodeficiency virus type 1 (HIV-1) during budding. The mechanism for HLA class II protein incorporation is not known and may involve a viral protein. To determine whether Env affects HLA class II protein incorporation, HIV-1 virions, either with or without Env on their surface, were produced from HLA class II-expressing cells and analyzed by whole-virus immunoprecipitation with antisera against HLA class II proteins. HLA class II proteins were detected on virions only when wild-type Env was incorporated, while similar experiments showed that HLA class I proteins were incorporated independent of Env packaging. Therefore, the packaging of HIV-1 Env protein is required for the efficient incorporation of HLA class II but not class I proteins into the virion. Analysis of two Env mutants revealed that the presence of a 43-amino-acid sequence between amino acids 708 and 750 in the gp41(TM) cytoplasmic tail was required for efficient incorporation of HLA class II proteins. These data show that HIV-1 actively incorporates HLA class II proteins in a process that, either directly or indirectly, requires Env.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-10233963, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-1357190, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-1470916, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-1604808, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-1604822, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-1847504, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-1993862, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-2023946, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-2156628, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-2191147, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-2357375, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-3127528, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-3640832, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-6757385, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-7602119, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-7824947, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-8035484, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-8151760, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-8396259, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-8416370, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-8610464, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-8679286, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-8794289, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-8955046, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-8995692, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-9032323, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-9126268, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-9126269, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-9136877, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-9225051, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-9624176, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-9837788, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-9847302, http://linkedlifedata.com/resource/pubmed/commentcorrection/10729169-9882340
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
74
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3918-23
pubmed:dateRevised
2010-9-13
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Efficient incorporation of HLA class II onto human immunodeficiency virus type 1 requires envelope glycoprotein packaging.
pubmed:affiliation
AIDS Vaccine Program, SAIC Frederick, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.